X4 Pharmaceuticals Ownership | Who Owns X4 Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

X4 Pharmaceuticals Ownership Summary


X4 Pharmaceuticals is owned by 213.84% institutional investors, 0.61% insiders. Vanguard group is the largest institutional shareholder, holding 46.18% of XFOR shares. Fidelity Small Cap Growth is the top mutual fund, with 3.59% of its assets in X4 Pharmaceuticals shares.

XFOR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockX4 Pharmaceuticals213.84%0.61%-114.44%
SectorHealthcare Stocks 50.59%12.40%37.01%
IndustryBiotech Stocks 49.10%12.14%38.76%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group3.42M46.18%$13.69M
Morgan stanley9.47M22.38%$39.10M
Empery asset management, lp8.94M21.15%$36.94M
Fmr8.10M19.16%$33.47M
Bain capital life sciences investors7.97M18.84%$32.91M
Perceptive advisors6.74M15.93%$27.83M
Saturn v capital management6.46M15.27%$26.67M
Deep track capital, lp6.34M14.99%$26.18M
Kingdon capital management933.33K12.59%$3.19M
Braidwell lp3.27M7.74%$13.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Empery asset management, lp8.94M44.50%$36.94M
Rosalind advisors3.21M5.33%$13.28M
Saturn v capital management6.46M4.83%$26.67M
Bain capital life sciences investors7.97M2.97%$32.91M
Caxton15.56K1.60%$64.25K
Samsara biocapital1.83M0.74%$7.57M
Stonepine capital management335.31K0.55%$1.38M
Perceptive advisors6.74M0.54%$27.83M
Braidwell lp3.27M0.45%$13.52M
Deep track capital, lp6.34M0.43%$26.18M

Top Buyers

HolderShares% AssetsChange
Vanguard group3.42M0.00%3.01M
Blackrock10.68M0.00%1.94M
Deep track capital, lp6.34M0.43%1.33M
Morgan stanley9.47M0.00%1.26M
Susquehanna group, llp856.22K0.00%834.09K

Top Sellers

HolderShares% AssetsChange
Nea management company499.56K0.07%-14.49M
Orbimed advisors---6.78M
Adage capital partners gp---4.28M
Soleus capital management---4.05M
Avidity partners management lp---2.41M

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust480.73K0.00%480.73K$1.99M
Boothbay fund management343.96K0.02%343.96K$1.18M
Vr adviser330.52K0.05%330.52K$1.37M
Wolverine trading39.66K-39.66K$32.05K
Vanguard global advisers32.98K0.00%32.98K$136.19K

Sold Out

HolderChange
True wealth design-3.00
Northwestern mutual wealth management-5.00
Frazier financial advisors-10.00
Headlands-16.00
Nelson, van denburg & campbell wealth management group-22.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026816.58%90,437,6405.26%2130.02%39-30.36%22214.29%
Dec 31, 202539-4.88%36,993,131170.97%4991.47%3042.86%4-55.56%
Sep 30, 202522-55.10%3,669,96333.55%493.60%10-16.67%5-86.11%
Jun 30, 202532-66.67%1,495,756-98.48%-1028.22%8-80.95%23-4.17%
Mar 31, 2025961.05%98,519,817-1.31%10.06%4210.53%249.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Small Cap Growth3.39M3.59%-
Vanguard US Total Market Shares ETF5.03M2.90%1.00
Vanguard Morn Total Stk Mkt Idx Investor2.60M2.76%113.50K
Vanguard Total Stock Mkt Idx Inv2.60M2.76%113.50K
Vanguard MStar Total Stk Mkt Idx Invest2.60M2.62%-
Morgan Stanley Inst Inception I2.31M2.33%-24.89K
Morgan Stanley Inception2.31M2.33%-24.89K
iShares Russell 2000 ETF1.95M2.06%-34.56K
EQ/Morgan Stanley Small Cap Growth K1.82M1.83%-
Fidelity Small Cap Growth K61.69M1.79%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 12, 2026Volpone John PresidentSell$109.23K
Aug 12, 2026Craig Adam R Executive ChairmanSell$210.83K
Jun 30, 2026KIRSKE DAVID Chief Financial OfficerSell$36.43K
May 12, 2026KIRSKE DAVID Chief Financial OfficerSell$72.82K
Oct 23, 2025Craig Adam R Executive ChairmanBuy$250.00K

Insider Transactions Trends


DateBuySell
2026 Q3-2
2026 Q2-2
2026 Q1--
2025 Q41-
2025 Q3--

XFOR Ownership FAQ


Who Owns X4 Pharmaceuticals?

X4 Pharmaceuticals shareholders are primarily institutional investors at 213.84%, followed by 0.61% insiders and -114.45% retail investors. The average institutional ownership in X4 Pharmaceuticals's industry, Biotech Stocks , is 49.10%, which X4 Pharmaceuticals exceeds.

Who owns the most shares of X4 Pharmaceuticals?

X4 Pharmaceuticals’s largest shareholders are Vanguard group (3.42M shares, 46.18%), Morgan stanley (9.47M shares, 22.38%), and Empery asset management, lp (8.94M shares, 21.15%). Together, they hold 89.72% of X4 Pharmaceuticals’s total shares outstanding.

Does Blackrock own X4 Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of X4 Pharmaceuticals.

Who is X4 Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Empery asset management, lp is X4 Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 44.50% of its assets in 8.94M X4 Pharmaceuticals shares, valued at 36.94M$.

Who is the top mutual fund holder of X4 Pharmaceuticals shares?

Fidelity Small Cap Growth is the top mutual fund holder of X4 Pharmaceuticals shares, with 3.59% of its total shares outstanding invested in 3.39M X4 Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools